vs
艾伯维(ARGX)与美盛公司(MOS)财务数据对比。点击上方公司名可切换其他公司
美盛公司的季度营收约是艾伯维的1.2倍($3.0B vs $2.5B),艾伯维净利率更高(35.5% vs -17.5%,领先52.9%),艾伯维同比增速更快(83.2% vs 5.6%),艾伯维自由现金流更多($322.4M vs $-405.7M)
艾伯维是总部位于美国伊利诺伊州北芝加哥的制药企业,研发生产的药物覆盖多种疾病治疗领域,可满足多元临床需求,致力于为全球不同病症的患者提供可靠的治疗方案选择。
美盛公司(The Mosaic Company)是总部位于美国佛罗里达州坦帕的化工企业,主营磷矿、钾矿开采及尿素采集,依托多元国际分销网络和旗下肥料业务板块生产销售农用肥料,是美国规模最大的钾肥、磷肥生产商。
ARGX vs MOS — 直观对比
营收规模更大
MOS
是对方的1.2倍
$2.5B
营收增速更快
ARGX
高出77.6%
5.6%
净利率更高
ARGX
高出52.9%
-17.5%
自由现金流更多
ARGX
多$728.1M
$-405.7M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $2.5B | $3.0B |
| 净利润 | $877.2M | $-519.5M |
| 毛利率 | 89.5% | 11.5% |
| 营业利润率 | 28.9% | -3.4% |
| 净利率 | 35.5% | -17.5% |
| 营收同比 | 83.2% | 5.6% |
| 净利润同比 | 1.3% | -407.4% |
| 每股收益(稀释后) | $13.25 | $-1.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ARGX
MOS
| Q4 25 | $2.5B | $3.0B | ||
| Q3 25 | — | $3.5B | ||
| Q2 25 | $1.8B | $3.0B | ||
| Q1 25 | — | $2.6B | ||
| Q4 24 | $1.4B | $2.8B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | $901.9M | $2.8B | ||
| Q1 24 | — | $2.7B |
净利润
ARGX
MOS
| Q4 25 | $877.2M | $-519.5M | ||
| Q3 25 | — | $411.4M | ||
| Q2 25 | $414.8M | $410.7M | ||
| Q1 25 | — | $238.1M | ||
| Q4 24 | $865.6M | $169.0M | ||
| Q3 24 | — | $122.2M | ||
| Q2 24 | $-32.5M | $-161.5M | ||
| Q1 24 | — | $45.2M |
毛利率
ARGX
MOS
| Q4 25 | 89.5% | 11.5% | ||
| Q3 25 | — | 16.0% | ||
| Q2 25 | 89.2% | 17.3% | ||
| Q1 25 | — | 18.6% | ||
| Q4 24 | 90.2% | 10.7% | ||
| Q3 24 | — | 14.8% | ||
| Q2 24 | 89.4% | 14.0% | ||
| Q1 24 | — | 14.9% |
营业利润率
ARGX
MOS
| Q4 25 | 28.9% | -3.4% | ||
| Q3 25 | — | 9.8% | ||
| Q2 25 | 19.2% | 8.1% | ||
| Q1 25 | — | 12.9% | ||
| Q4 24 | 8.7% | 3.5% | ||
| Q3 24 | — | 4.1% | ||
| Q2 24 | -15.4% | 8.3% | ||
| Q1 24 | — | 6.5% |
净利率
ARGX
MOS
| Q4 25 | 35.5% | -17.5% | ||
| Q3 25 | — | 11.9% | ||
| Q2 25 | 23.4% | 13.7% | ||
| Q1 25 | — | 9.1% | ||
| Q4 24 | 64.1% | 6.0% | ||
| Q3 24 | — | 4.3% | ||
| Q2 24 | -3.6% | -5.7% | ||
| Q1 24 | — | 1.7% |
每股收益(稀释后)
ARGX
MOS
| Q4 25 | $13.25 | $-1.63 | ||
| Q3 25 | — | $1.29 | ||
| Q2 25 | $6.32 | $1.29 | ||
| Q1 25 | — | $0.75 | ||
| Q4 24 | $13.33 | $0.53 | ||
| Q3 24 | — | $0.38 | ||
| Q2 24 | $-0.55 | $-0.50 | ||
| Q1 24 | — | $0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $3.5B | $276.6M |
| 总债务越低越好 | — | $4.3B |
| 股东权益账面价值 | $7.3B | $12.1B |
| 总资产 | $8.7B | $24.5B |
| 负债/权益比越低杠杆越低 | — | 0.35× |
8季度趋势,按日历期对齐
现金及短期投资
ARGX
MOS
| Q4 25 | $3.5B | $276.6M | ||
| Q3 25 | — | $153.3M | ||
| Q2 25 | $2.1B | $286.2M | ||
| Q1 25 | — | $259.2M | ||
| Q4 24 | $1.5B | $272.8M | ||
| Q3 24 | — | $301.6M | ||
| Q2 24 | $1.4B | $322.0M | ||
| Q1 24 | — | $336.7M |
总债务
ARGX
MOS
| Q4 25 | — | $4.3B | ||
| Q3 25 | — | $3.4B | ||
| Q2 25 | — | $3.3B | ||
| Q1 25 | — | $3.3B | ||
| Q4 24 | — | $3.3B | ||
| Q3 24 | — | $3.2B | ||
| Q2 24 | $11.0M | $3.2B | ||
| Q1 24 | — | $3.2B |
股东权益
ARGX
MOS
| Q4 25 | $7.3B | $12.1B | ||
| Q3 25 | — | $12.8B | ||
| Q2 25 | $6.1B | $12.4B | ||
| Q1 25 | — | $11.8B | ||
| Q4 24 | $5.5B | $11.5B | ||
| Q3 24 | — | $11.8B | ||
| Q2 24 | $4.3B | $11.7B | ||
| Q1 24 | — | $12.0B |
总资产
ARGX
MOS
| Q4 25 | $8.7B | $24.5B | ||
| Q3 25 | — | $24.7B | ||
| Q2 25 | $7.2B | $24.3B | ||
| Q1 25 | — | $23.2B | ||
| Q4 24 | $6.2B | $22.9B | ||
| Q3 24 | — | $23.3B | ||
| Q2 24 | $4.8B | $22.6B | ||
| Q1 24 | — | $22.9B |
负债/权益比
ARGX
MOS
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 0.28× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 0.27× | ||
| Q2 24 | 0.00× | 0.27× | ||
| Q1 24 | — | 0.27× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $323.3M | $-56.1M |
| 自由现金流经营现金流 - 资本支出 | $322.4M | $-405.7M |
| 自由现金流率自由现金流/营收 | 13.0% | -13.6% |
| 资本支出强度资本支出/营收 | 0.0% | 11.8% |
| 现金转化率经营现金流/净利润 | 0.37× | — |
| 过去12个月自由现金流最近4个季度 | $594.5M | $-534.6M |
8季度趋势,按日历期对齐
经营现金流
ARGX
MOS
| Q4 25 | $323.3M | $-56.1M | ||
| Q3 25 | — | $228.5M | ||
| Q2 25 | $361.8M | $609.5M | ||
| Q1 25 | — | $42.9M | ||
| Q4 24 | $41.9M | $219.3M | ||
| Q3 24 | — | $312.9M | ||
| Q2 24 | $-124.7M | $847.0M | ||
| Q1 24 | — | $-80.0M |
自由现金流
ARGX
MOS
| Q4 25 | $322.4M | $-405.7M | ||
| Q3 25 | — | $-135.9M | ||
| Q2 25 | $356.6M | $304.9M | ||
| Q1 25 | — | $-297.9M | ||
| Q4 24 | $40.9M | $-74.8M | ||
| Q3 24 | — | $72.1M | ||
| Q2 24 | $-125.5M | $513.1M | ||
| Q1 24 | — | $-463.0M |
自由现金流率
ARGX
MOS
| Q4 25 | 13.0% | -13.6% | ||
| Q3 25 | — | -3.9% | ||
| Q2 25 | 20.1% | 10.1% | ||
| Q1 25 | — | -11.4% | ||
| Q4 24 | 3.0% | -2.7% | ||
| Q3 24 | — | 2.6% | ||
| Q2 24 | -13.9% | 18.2% | ||
| Q1 24 | — | -17.3% |
资本支出强度
ARGX
MOS
| Q4 25 | 0.0% | 11.8% | ||
| Q3 25 | — | 10.6% | ||
| Q2 25 | 0.3% | 10.1% | ||
| Q1 25 | — | 13.0% | ||
| Q4 24 | 0.1% | 10.4% | ||
| Q3 24 | — | 8.6% | ||
| Q2 24 | 0.1% | 11.9% | ||
| Q1 24 | — | 14.3% |
现金转化率
ARGX
MOS
| Q4 25 | 0.37× | — | ||
| Q3 25 | — | 0.56× | ||
| Q2 25 | 0.87× | 1.48× | ||
| Q1 25 | — | 0.18× | ||
| Q4 24 | 0.05× | 1.30× | ||
| Q3 24 | — | 2.56× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -1.77× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图